REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,336,002 | +9.8% | 8,402 | -2.3% | 0.27% | +15.9% |
| Q2 2023 | $1,216,556 | +80627.0% | 8,600 | -3.9% | 0.23% | -32.2% |
| Q1 2023 | $1,507 | -4.7% | 8,949 | -4.2% | 0.34% | +0.9% |
| Q4 2022 | $1,582 | -99.9% | 9,342 | -4.4% | 0.34% | -14.8% |
| Q3 2022 | $1,828,000 | -8.7% | 9,767 | -20.8% | 0.40% | -5.7% |
| Q2 2022 | $2,002,000 | -15.9% | 12,330 | -2.6% | 0.42% | +6.6% |
| Q1 2022 | $2,380,000 | -36.1% | 12,655 | -10.0% | 0.40% | -33.4% |
| Q4 2021 | $3,724,000 | -16.9% | 14,063 | -9.3% | 0.60% | -23.7% |
| Q3 2021 | $4,479,000 | +36.2% | 15,500 | -5.9% | 0.78% | +36.8% |
| Q2 2021 | $3,289,000 | -0.6% | 16,477 | -3.2% | 0.57% | -5.6% |
| Q1 2021 | $3,310,000 | -18.4% | 17,028 | -19.6% | 0.60% | -17.9% |
| Q4 2020 | $4,058,000 | +19.1% | 21,175 | -8.3% | 0.74% | +2.1% |
| Q3 2020 | $3,406,000 | +15.9% | 23,085 | -2.9% | 0.72% | -17.7% |
| Q2 2020 | $2,938,000 | +20.9% | 23,765 | -5.6% | 0.88% | -4.6% |
| Q1 2020 | $2,430,000 | -1.5% | 25,170 | -5.6% | 0.92% | +28.6% |
| Q4 2019 | $2,466,000 | +17.5% | 26,661 | -2.5% | 0.71% | +8.5% |
| Q3 2019 | $2,098,000 | -12.6% | 27,357 | -2.1% | 0.66% | -11.2% |
| Q2 2019 | $2,401,000 | +37.9% | 27,932 | -5.2% | 0.74% | +45.6% |
| Q1 2019 | $1,741,000 | +2.0% | 29,461 | -9.0% | 0.51% | -10.2% |
| Q4 2018 | $1,707,000 | -10.1% | 32,374 | -5.4% | 0.57% | +6.0% |
| Q3 2018 | $1,898,000 | +15.6% | 34,229 | -1.9% | 0.54% | +6.6% |
| Q2 2018 | $1,642,000 | +25.2% | 34,904 | -3.7% | 0.50% | +21.5% |
| Q1 2018 | $1,311,000 | -2.7% | 36,234 | -2.4% | 0.41% | +3.5% |
| Q4 2017 | $1,347,000 | -10.8% | 37,134 | -5.8% | 0.40% | -14.9% |
| Q3 2017 | $1,510,000 | -8.3% | 39,404 | -0.8% | 0.47% | -3.1% |
| Q2 2017 | $1,647,000 | +16.0% | 39,734 | -1.5% | 0.48% | +0.4% |
| Q1 2017 | $1,420,000 | +12.6% | 40,339 | -1.4% | 0.48% | +12.1% |
| Q4 2016 | $1,261,000 | -4.8% | 40,914 | -6.8% | 0.43% | -6.7% |
| Q3 2016 | $1,325,000 | +9.6% | 43,880 | -0.7% | 0.46% | +7.0% |
| Q2 2016 | $1,209,000 | -5.8% | 44,180 | -7.7% | 0.43% | -9.8% |
| Q1 2016 | $1,284,000 | -7.9% | 47,880 | -2.8% | 0.48% | -7.9% |
| Q4 2015 | $1,394,000 | -0.1% | 49,280 | -1.6% | 0.52% | -7.8% |
| Q3 2015 | $1,395,000 | -68.4% | 50,090 | -53.1% | 0.56% | -64.7% |
| Q2 2015 | $4,412,000 | +32.7% | 106,905 | -2.4% | 1.59% | +34.7% |
| Q1 2015 | $3,325,000 | +36.6% | 109,535 | -10.9% | 1.18% | +34.6% |
| Q4 2014 | $2,435,000 | +0.8% | 122,985 | +1.4% | 0.88% | -2.7% |
| Q3 2014 | $2,416,000 | -26.7% | 121,325 | -16.1% | 0.90% | -24.7% |
| Q2 2014 | $3,295,000 | +120.8% | 144,600 | +24.6% | 1.20% | +113.7% |
| Q1 2014 | $1,492,000 | -16.3% | 116,050 | -11.2% | 0.56% | -13.7% |
| Q4 2013 | $1,782,000 | +58.0% | 130,675 | +28.4% | 0.65% | +50.5% |
| Q3 2013 | $1,128,000 | – | 101,750 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |